TrialArthritis research & therapy2017

Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study.

Barbara Vigone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.